Large-Scale Expansion of Dendritic Cell-Primed Polyclonal Human Cytotoxic T-Lymphocyte Lines Using Lymphoblastoid Cell Lines for Adoptive Immunotherapy

Uluhan Sili, M. Helen Huls, Alan R. Davis, Stephen Gottschalk, Malcolm Brenner, Helen Heslop, Cliona M. Rooney

Research output: Contribution to journalArticle

56 Scopus citations

Abstract

Dendritic cells (DCs) have been shown to activate cytotoxic T-lymphocytes (CTLs) for many tumor and virus-associated antigens in vitro. In this study, the authors tested the feasibility of using DCs to expand polyclonal, cytomegalovirus (CMV)-specific CTL lines for adoptive immunotherapy. Two stimulations with DCs expressing pp65, the immunodominant antigen of CMV, effectively activated and expanded MHC-class I restricted, CMV-specific CTLs from peripheral blood mononuclear cells. However, limiting monocyte-derived DC numbers precluded the authors from expanding the CTLs to the numbers required for adoptive transfer protocols. Nonspecific stimulation methods failed to expand CTL lines specifically. However, the authors found that lymphoblastoid cell lines (LCLs) expressing pp65 expanded pp65-specific CTL lines without competition from EBV-specific CTLs. An unlimited source of antigen presenting cells that could present antigen in the appropriate MHC context emerged as a critical point for expansion of polyclonal, antigen-specific CTL lines.

Original languageEnglish (US)
Pages (from-to)241-256
Number of pages16
JournalJournal of Immunotherapy
Volume26
Issue number3
DOIs
StatePublished - Jan 1 2003

Keywords

  • CTL
  • Dendritic cell
  • Human
  • Transplantation
  • Viral

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Immunology

Fingerprint Dive into the research topics of 'Large-Scale Expansion of Dendritic Cell-Primed Polyclonal Human Cytotoxic T-Lymphocyte Lines Using Lymphoblastoid Cell Lines for Adoptive Immunotherapy'. Together they form a unique fingerprint.

Cite this